Trials / NCT01920867
Stem Cell Ophthalmology Treatment Study
Status unknown N/A Gene therapy, Cell therapy
- Sponsor
- MD Stem Cells
- Treatment
- RB (Retrobulbar); ST (Subtenon); IV (Intravenous); IVIT (Intravitreal); IO (Intraocular)
- Gene
- Not stated
- Conditions
- Retinal Disease, Macular Degeneration, Hereditary Retinal Dystrophy, Optic Nerve Disease, Glaucoma
- Ages
- 18 Years to no upper limit
- Enrollment
- 300 participants
- Started
- 2012-08
- Main results expected
- 2020-07
- Results posted
- Not yet
- Record last updated
- 2019-10-23
What the study is testing
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease. http://mdstemcells.com/scots-ii/
Where it runs
United States (1)
- MD Stem Cells, Westport, Connecticut